Report Detail
Global Pet Biopharmaceuticals Market Growth (Status and Outlook) 2021-2026
- RnM4298146 |
- 30 March, 2021 |
- Global |
- 105 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
According to this latest study, the 2021 growth of Pet Biopharmaceuticals will have significant change from previous year. By the most conservative estimates of global Pet Biopharmaceuticals market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Pet Biopharmaceuticals market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Biopharmaceuticals market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Antiparasitic
Biological Products
Antibacterial
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Prevention
Treatment
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pet Biopharmaceuticals Market Size 2016-2026
- 2.1.2 Pet Biopharmaceuticals Market Size CAGR by Region 2020 VS 2021 VS 2026
- 2.2 Pet Biopharmaceuticals Segment by Type
- 2.2.1 Antiparasitic
- 2.2.2 Antiparasitic
- 2.2.3 Antibacterial
- 2.2.4 Others
- 2.3 Pet Biopharmaceuticals Market Size by Type
- 2.3.1 Global Pet Biopharmaceuticals Market Size CAGR by Type
- 2.3.2 Global Pet Biopharmaceuticals Market Size Market Share by Type (2016-2021)
- 2.4 Pet Biopharmaceuticals Segment by Application
- 2.4.1 Prevention
- 2.4.2 Treatment
- 2.5 Pet Biopharmaceuticals Market Size by Application
- 2.5.1 Global Pet Biopharmaceuticals Market Size CAGR by Application
- 2.5.2 Global Pet Biopharmaceuticals Market Size Market Share by Application (2016-2021)
3 Pet Biopharmaceuticals Market Size by Players
- 3.1 Pet Biopharmaceuticals Market Size Market Share by Players
- 3.1.1 Global Pet Biopharmaceuticals Revenue by Players (2019-2021E)
- 3.1.2 Global Pet Biopharmaceuticals Revenue Market Share by Players (2019-2021E)
- 3.2 Global Pet Biopharmaceuticals Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Pet Biopharmaceuticals by Regions
- 4.1 Pet Biopharmaceuticals Market Size by Regions (2016-2021)
- 4.2 Americas Pet Biopharmaceuticals Market Size Growth (2016-2021)
- 4.3 APAC Pet Biopharmaceuticals Market Size Growth (2016-2021)
- 4.4 Europe Pet Biopharmaceuticals Market Size Growth (2016-2021)
- 4.5 Middle East & Africa Pet Biopharmaceuticals Market Size Growth (2016-2021)
5 Americas
- 5.1 Americas Pet Biopharmaceuticals Market Size by Country (2016-2021)
- 5.2 Americas Pet Biopharmaceuticals Market Size by Type (2016-2021)
- 5.3 Americas Pet Biopharmaceuticals Market Size by Application (2016-2021)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Pet Biopharmaceuticals Market Size by Region (2016-2021)
- 6.2 APAC Pet Biopharmaceuticals Market Size by Type (2016-2021)
- 6.3 APAC Pet Biopharmaceuticals Market Size by Application (2016-2021)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Pet Biopharmaceuticals by Country (2016-2021)
- 7.2 Europe Pet Biopharmaceuticals Market Size by Type (2016-2021)
- 7.3 Europe Pet Biopharmaceuticals Market Size by Application (2016-2021)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Pet Biopharmaceuticals by Region (2016-2021)
- 8.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2016-2021)
- 8.3 Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2016-2021)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Pet Biopharmaceuticals Market Forecast
- 10.1 Global Pet Biopharmaceuticals Forecast by Regions (2021-2026)
- 10.1.1 Global Pet Biopharmaceuticals Forecast by Regions (2021-2026)
- 10.1.2 Americas Pet Biopharmaceuticals Forecast
- 10.1.3 APAC Pet Biopharmaceuticals Forecast
- 10.1.4 Europe Pet Biopharmaceuticals Forecast
- 10.1.5 Middle East & Africa Pet Biopharmaceuticals Forecast
- 10.2 Americas Pet Biopharmaceuticals Forecast by Countries (2021-2026)
- 10.2.1 United States Pet Biopharmaceuticals Market Forecast
- 10.2.2 Canada Pet Biopharmaceuticals Market Forecast
- 10.2.3 Mexico Pet Biopharmaceuticals Market Forecast
- 10.2.4 Brazil Pet Biopharmaceuticals Market Forecast
- 10.3 APAC Pet Biopharmaceuticals Forecast by Region (2021-2026)
- 10.3.1 China Pet Biopharmaceuticals Market Forecast
- 10.3.2 Japan Pet Biopharmaceuticals Market Forecast
- 10.3.3 Korea Pet Biopharmaceuticals Market Forecast
- 10.3.4 Southeast Asia Pet Biopharmaceuticals Market Forecast
- 10.3.5 India Pet Biopharmaceuticals Market Forecast
- 10.3.6 Australia Pet Biopharmaceuticals Market Forecast
- 10.4 Europe Pet Biopharmaceuticals Forecast by Country (2021-2026)
- 10.4.1 Germany Pet Biopharmaceuticals Market Forecast
- 10.4.2 France Pet Biopharmaceuticals Market Forecast
- 10.4.3 UK Pet Biopharmaceuticals Market Forecast
- 10.4.4 Italy Pet Biopharmaceuticals Market Forecast
- 10.4.5 Russia Pet Biopharmaceuticals Market Forecast
- 10.5 Middle East & Africa Pet Biopharmaceuticals Forecast by Region (2021-2026)
- 10.5.1 Egypt Pet Biopharmaceuticals Market Forecast
- 10.5.2 South Africa Pet Biopharmaceuticals Market Forecast
- 10.5.3 Israel Pet Biopharmaceuticals Market Forecast
- 10.5.4 Turkey Pet Biopharmaceuticals Market Forecast
- 10.5.5 GCC Countries Pet Biopharmaceuticals Market Forecast
- 10.6 Global Pet Biopharmaceuticals Forecast by Type (2021-2026)
- 10.7 Global Pet Biopharmaceuticals Forecast by Application (2021-2026)
11 Key Players Analysis
- 11.1 Zoetis
- 11.1.1 Zoetis Company Information
- 11.1.2 Zoetis Pet Biopharmaceuticals Product Offered
- 11.1.3 Zoetis Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
- 11.1.4 Zoetis Main Business Overview
- 11.1.5 Zoetis Latest Developments
- 11.2 Boehringer Ingelheim
- 11.2.1 Boehringer Ingelheim Company Information
- 11.2.2 Boehringer Ingelheim Pet Biopharmaceuticals Product Offered
- 11.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
- 11.2.4 Boehringer Ingelheim Main Business Overview
- 11.2.5 Boehringer Ingelheim Latest Developments
- 11.3 Merck
- 11.3.1 Merck Company Information
- 11.3.2 Merck Pet Biopharmaceuticals Product Offered
- 11.3.3 Merck Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
- 11.3.4 Merck Main Business Overview
- 11.3.5 Merck Latest Developments
- 11.4 Elanco
- 11.4.1 Elanco Company Information
- 11.4.2 Elanco Pet Biopharmaceuticals Product Offered
- 11.4.3 Elanco Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
- 11.4.4 Elanco Main Business Overview
- 11.4.5 Elanco Latest Developments
- 11.5 Virbac
- 11.5.1 Virbac Company Information
- 11.5.2 Virbac Pet Biopharmaceuticals Product Offered
- 11.5.3 Virbac Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
- 11.5.4 Virbac Main Business Overview
- 11.5.5 Virbac Latest Developments
- 11.6 Dechra Veterinary Products
- 11.6.1 Dechra Veterinary Products Company Information
- 11.6.2 Dechra Veterinary Products Pet Biopharmaceuticals Product Offered
- 11.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
- 11.6.4 Dechra Veterinary Products Main Business Overview
- 11.6.5 Dechra Veterinary Products Latest Developments
- 11.7 Ceva
- 11.7.1 Ceva Company Information
- 11.7.2 Ceva Pet Biopharmaceuticals Product Offered
- 11.7.3 Ceva Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
- 11.7.4 Ceva Main Business Overview
- 11.7.5 Ceva Latest Developments
- 11.8 Vetoquinol
- 11.8.1 Vetoquinol Company Information
- 11.8.2 Vetoquinol Pet Biopharmaceuticals Product Offered
- 11.8.3 Vetoquinol Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
- 11.8.4 Vetoquinol Main Business Overview
- 11.8.5 Vetoquinol Latest Developments
- 11.9 Ouro Fino Saude
- 11.9.1 Ouro Fino Saude Company Information
- 11.9.2 Ouro Fino Saude Pet Biopharmaceuticals Product Offered
- 11.9.3 Ouro Fino Saude Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
- 11.9.4 Ouro Fino Saude Main Business Overview
- 11.9.5 Ouro Fino Saude Latest Developments
- 11.10 Norbrook
- 11.10.1 Norbrook Company Information
- 11.10.2 Norbrook Pet Biopharmaceuticals Product Offered
- 11.10.3 Norbrook Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
- 11.10.4 Norbrook Main Business Overview
- 11.10.5 Norbrook Latest Developments
11. Jindun
- 11.11.1 Jindun Company Information
- 11.11.2 Jindun Pet Biopharmaceuticals Product Offered
- 11.11.3 Jindun Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
- 11.11.4 Jindun Main Business Overview
- 11.11.5 Jindun Latest Developments
- 11.12.1 Chopperlvya Animal Health Company Information
- 11.12.2 Chopperlvya Animal Health Pet Biopharmaceuticals Product Offered
- 11.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
- 11.12.4 Chopperlvya Animal Health Main Business Overview
- 11.12.5 Chopperlvya Animal Health Latest Developments
- 11.13.1 CAHIC Company Information
- 11.13.2 CAHIC Pet Biopharmaceuticals Product Offered
Summary:
Get latest Market Research Reports on Pet Biopharmaceuticals. Industry analysis & Market Report on Pet Biopharmaceuticals is a syndicated market report, published as Global Pet Biopharmaceuticals Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of Pet Biopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
